IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Colorectal cancer is a leading cause of cancer-related deaths worldwide. Chronic inflammation is recognized as a predisposing factor for the development of colon cancer, but the molecular mechanisms linking inflammation and tumorigenesis have remained elusive. Recent studies revealed a crucial role for the NOD-like receptor protein Nlrp3 in regulating inflammation through the assembly of proinflammatory protein complexes termed inflammasomes. However, its role in colorectal tumor formation remains unclear. In this study, we showed that mice deficient for Nlrp3 or the inflammasome effector caspase-1 were highly susceptible to azoxymethane/dextran sodium sulfate-induced inflammation and suffered from dramatically increased tumor burdens in the colon. This was a consequence of markedly reduced IL-18 levels in mice lacking components of the Nlrp3 inflammasome, which led to impaired production and activation of the tumor suppressors IFN-γ and STAT1, respectively. Thus, IL-18 production downstream of the Nlrp3 inflammasome is critically involved in protection against colorectal tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Experimental — accuracy not yet measuredIn the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 1×
“The synthesis and secretion of these cytokines is controlled by transcription factors of the STAT, NF-kB, and AP-1 families (6).”
BackgroundDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 1×
“in the NLR protein NOD2 are linked with the development of Crohn’s disease in humans (41, 42).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 1×
“in the NLR protein NOD2 are linked with the development of Crohn’s disease in humans (41, 42).”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896 · cited 1×
“Indeed, IL-18 was originally identified as the “IFN-g–inducing factor” (22), and IFN-g has been described as a pleiotropic cytokine with potent antitumor activity (34, 37).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Cited by
Items 301–400 of 457
Wu, J., Lu, L., Wang, C., & Jiang, F. (2022) · Journal of Oncology · doi:10.1155/2022/8164756 · Cited by 10
Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors
Lou, S., Wu, M., & Cui, S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673289984231127062528 · Cited by 10
Wang, Z., Wang, N., Zheng, Y., & Wang, S. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_12 · Cited by 10
Ursolic acid inhibits the invasiveness of A498 cells via NLRP3 inflammasome activation
Chen, Y.-M., Tang, B.-X., Chen, W.-Y., & Zhao, M. (2020) · Oncology Letters · doi:10.3892/ol.2020.12027 · Cited by 10
Ghanavat, M., Arjmand, B., & Rahim, F. (2022) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-022-00805-3 · Cited by 10
“(2010) [30, 31] Anti-tumoral Nlrp3, Pycard, and Casp-1 DSS-colitis model C57BL/6 mice 27 Nlrp3 inflammasome involves in the maintenance of intestinal homeostasis and protection against colitis TNFα”
BackgroundLee, S. R., Park, Y. K., Shin, B. A., & Park, H.-R. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.009 · Cited by 10
“IL-18 studies for antitumor effects have been investigated in studies of many mouse tumor [36] and human cancer treatments [37].”
BackgroundPyroptosis: Turning Up the Heat on Cancer
Zhang, Z., & Lieberman, J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-041848 · Cited by 10
Imbalanced IL-1B and IL-18 Expression in Sézary Syndrome
Manfrere, K. C. G., Torrealba, M. P., Ferreira, F. M., de Sousa, E. S. A., Miyashiro, D., Teixeira, F. M. E., Alberca, R. W., Nakaya, H. I., Ramos, Y. Á. L., Sotto, M. N., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054674 · Cited by 9
“IL-18 is able to cooperate with IL-12 to induce IFN-γ production, leading to NK-cell activation, T-helper type-1 cell skewing, upregulated antigen presentation, and antiviral and antitumor functions [15].”
BackgroundInflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling
Műzes, G., & Sípos, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116167 · Cited by 9
“These variables may contribute to an increased susceptibility to DSS-induced colitis and the progression of CAC [14].”
BackgroundShimane, T., Kobayashi, H., Takeoka, M., Kitazawa, M., Matsumura, T., Hida, S., Xiao, T., Koike, T., Taniguchi, S., & Kurita, H. (2013) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2013.03.013 · Cited by 9
Predictive Values of Colon Microbiota in the Treatment Response to Colorectal Cancer
Ros, J. G., Ramos-Arenas, V., & Conesa‐Zamora, P. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0044 · Cited by 9
Deng, D., Liu, F., Liu, Z., Wu, Z., He, Y., Zhang, C., Zu, X., Ou, Z., & Wang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.965469 · Cited by 9
“Pyroptosis inhibits tumor growth in colorectal, liver, skin, and other cancers (6).”
BackgroundRole of STAT3 in Colorectal Cancer Development
Lakkim, V., Reddy, M. C., Prasad, D. V. R., & Lomada, D. (2017) · Springer eBooks · doi:10.1007/978-981-10-6728-0_19 · Cited by 8
Li, C., Pan, J., Jiang, Y., Wu, Y., Jin, Z., & Chen, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.788670 · Cited by 8
“Pyroptosis has shown antitumor effects through inhibiting the tumor growth in liver and gastric cancers while showing both suppression or promotion effects in BC (Zaki et al., 2010; Chen et al., 2012; Shao et al., 2021).”
BackgroundBilgin, E., Dızdar, Ö., Güven, D. C., Ceylan, S., Aybı, Ö., Fırlatan, B., Kardaş, R. C., Yıldırım, T., Hayran, M., Kalyoncu, U., et al. (2019) · Rheumatology International · doi:10.1007/s00296-019-04311-x · Cited by 8
Tummala, P., Rooke, M., Dahlstrom, J. E., Takahashi, S., Casarotto, M. G., Fernando, N., Hughes, M. M., O'Neill, L. A. J., & Philip G. Board (2021) · Carcinogenesis · doi:10.1093/carcin/bgab008 · Cited by 8
Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer
Azimi, M., Shahbaz, S. K., Mansourabadi, A. H., Khosroshahi, L. M., Pourkalhor, S., Rezakhani, M., & Masoumi, F. (2022) · International Archives of Allergy and Immunology · doi:10.1159/000525695 · Cited by 8
Calvello, R., Caponio, G. R., Cianciulli, A., Porro, C., Ruggiero, M., Celano, G., Angelis, M. D., & Panaro, M. A. (2025) · Antioxidants · doi:10.3390/antiox14030356 · Cited by 7
Lei, Y. L., Lui, V. W. Y., Grandis, J. R., & Egloff, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085619 · Cited by 7
Inflammasome-independent functions of NAIPs and NLRs in the intestinal epithelium
Scarfe, L., Mackie, G. M., & Maslowski, K. M. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210365 · Cited by 7
Huang, L., Zhang, P., Duan, S., Shao, H., Gao, M., Zhang, Q., & Feng, F. (2019) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.18-0159 · Cited by 7
“For example, NLRP3 inflammasomedeficient mice on a C57BL/6J genetic background, including NLRP3−/−, ASC−/− and Casp1−/− mice, were used to illuminate the critical role of NLRP3 inflammasome in colitis-associated colorectal tumor [10].”
MethodRole of gut microbiota in tumorigenesis and antitumoral therapies: an updated review
Singhal, S., Bhadana, R., Jain, B. P., Gautam, A., Pandey, S., & Rani, V. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2166268 · Cited by 7
“IL-18 is a suppressor of colitis (Zaki et al., 2010).”
Expression of biologically active murine interleukin-18 inLactococcus lactis
Feizollahzadeh, S., Khanahmad, H., Rahimmanesh, I., Ganjalıkhani-Hakemi, M., Andalib, A., Sanei, M. H., & Rezaei, A. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw234 · Cited by 7
Whitehead, L., & Brown, G. D. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch8 · Cited by 7
Zhou, X., Tao, Y., & Shi, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217283 · Cited by 6
Fang, J., Zhu, W., Yu, D., Zhu, L., Zha, H., Tang, J., Li, Y., Zhu, X., Zhao, T., & Zhang, W. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s498703 · Cited by 6
“92 Similarly, mice deficient in Asc and caspase-1 are more prone to colitis and colitis-associated cancer, 93 demonstrating the protective role of inflammasome in CRC-related inflammation models.”
Bacteria-assisted metal antitumor immunotherapy
Guo, J., Liang, J., Chen, Z., Pan, Y., He, Y., & Chao, H. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216938 · Cited by 6
Li, H., Chang, X., Wang, H., Peng, B., Wang, J., Zhang, P., & Zhang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.934835 · Cited by 6
Heng, Y., Bai, X., & Zheng, W. (2022) · Disease Markers · doi:10.1155/2022/9124216 · Cited by 6
Pyroptosis-related genes play a significant role in the prognosis of gastric cancer
Guan, S., Wang, X., Shang, P., Du, Q., Li, M., Xing, X., & Yan, B. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i24.8490 · Cited by 6
Gan, Y., Zhang, Z., Wang, X., Li, A., Fan, Y., & Zhang, Q. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/8224618 · Cited by 6
Ganesan, R., & Suk, K. T. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.10.031 · Cited by 6
Zhong, G., Guo, C., Shang, Y., Cui, Z., Zhou, M., Sun, M., Fu, Y., Zhang, L., Feng, H., & Chen, C. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1029717 · Cited by 5
“For instance, pyroptosis serves as a tumor inhibitor in hepatocellular and nasopharyngeal carcinoma (Zaki et al., 2010; Chen et al., 2012) and a twoedged sword of promotor and inhibitor in cervical cancer (Xia et al.”
BackgroundChen, W., Zhuang, X., Chen, W., Cai, Y., 朱冠保, Wang, P., & Tu, J. (2024) · Open Medicine · doi:10.1515/med-2023-0886 · Cited by 5
“It can be a tumor suppressor in colorectal cancer [17] and skin cancer [37]. lncRNA ADAMTS9-AS2 can inhibit GC cell viability by activating NLRP3-mediated pyroptosis [38].”
BackgroundHu, Y., Yoshida, K., COLOGNE, J. B., Maki, M., Morishita, Y., Sasaki, K., Hayashi, I., Ohishi, W., Hida, A., Kyoizumi, S., et al. (2015) · Human Genome Variation · doi:10.1038/hgv.2015.35 · Cited by 5
Deng, T., Cui, J., Lyon, C. J., Zhang, N., Wang, H. Y., Wang, R., & Hsueh, W. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_2 · Cited by 5
Ali, T., Saxena, R., Rani, I., Sharma, R., More, D., Ola, R. P., Agarwal, S., Chawla, Y. K., & Kaur, J. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04206-1 · Cited by 5
Cancer Pathogenesis and DNA Sensing
Shen, Y. J., Lam, A. R., Ho, S. W. S., Koo, C. X., Bert, N. L., & Gasser, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404732-7.00009-5 · Cited by 5
Hirota, S. A., Ueno, A., Tulk, S. E., Becker, H. M., Schenck, L. P., Potentier, M. S., Li, Y., Ghosh, S. K., Muruve, D. A., MacDonald, J. A., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/5637685 · Cited by 5
“, the loss of inflammasome signaling within the nonhematopoietic compartment conferred the susceptibility [34].”
BackgroundInfluentialGut Microbiota and Cancer Correlates
Malaviya, A., Paari, K. A., Malviya, S., Kondapalli, V. K., Ghosh, A., & Samuel, R. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_1 · Cited by 5
Pan, J., Jiang, Y., Li, C., Jin, T., Yu, K., & Jin, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.898236 · Cited by 5
Recent developments in cuproptosis of glioblastoma
Chen, Y., Zhang, J., & Xu, H. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155939 · Cited by 4
Jiang, D., Liu, X., Tan, R., Zhu, Y., & Li, Z. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5332 · Cited by 4
“Although it was originally reported that the inflammasome inhibits tumor growth by activating the immune system (19), increasing evidence has demonstrated that the activation of the inflammasome leads to cancer cell growth and promotes the process of cancer metastasis.”
BackgroundPYCARD (PYD and CARD domain containing)
Dunn, J., & Fujita, M. (2015) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/56440 · Cited by 4
“2015; 19(4) 294 NLRP3/ASC-dependent caspase-1 activity is critical for IL-18-mediated IFN-γ-dependent STAT1 tumor suppression of colorectal cancer triggered by chronic inflammation (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Zaki et al., 2010).”
Huang, X., Lu, Y., Li, S., Chen, W., Zheng, Q., Hou, Y., Tang, J., Zhang, S., Dong, J., & Yue, L. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153440 · Cited by 3
Innate Immune Pattern Recognition and the Development of Intestinal Cancer
Siegel, S. J., & Rakoff-Nahoum, S. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_14 · Cited by 3
Tian, B., Hua, Z., Wang, Z., & Wang, J. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01836-y · Cited by 3
RetractedThe Gut Microbiome and Colorectal Cancer
Yu, A. I., & Chen, G. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_3 · Cited by 3
Best Practice & Research Clinical
Savic, S., Dickie, L. J., Wittmann, M., & McDermott, M. (2012) · Cited by 3
Clinical study of IL-18 and NANOG gene polymorphisms in prostate cancer patients*
Nong, S., Guan, Y., Wang, Z., Wei, Z., Zhang, Y., Ni, J., He, C., Ma, L., Zhou, S., & Li, W. (2018) · Oncology and Translational Medicine · doi:10.1007/s10330-018-0308-8 · Cited by 3
Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy
Luo, J., Zhang, Q., Wang, S., Zheng, L., Liu, J., Zhang, Y., Wang, Y., Wang, R., Xiao, Z., & Li, Z. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096281451240306062101 · Cited by 2
Ashmore, A. A., Balasubramanian, B., Phillips, A., Asher, V., Bali, A., Ordóñez‐Morán, P., & Khan, R. N. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05988-9 · Cited by 2
rFIP-nha activates macrophages towards a pro-inflammatory phenotype via AIM2 inflammasome modulation
Liu, Y., Li, Z., Wichers, H. J., Bastiaan‐Net, S., & Hoppenbrouwers, T. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1533742 · Cited by 2
Yao, S., Chen, S., Wan, S., Wang, A., Liang, Z., Liu, X., Gao, Y., & Cai, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71278 · Cited by 2
Wang, Y., CHEN, J., Zhang, X., Ji, Z., Zhang, N., Li, N., Zhang, X., Zhao, S., Li, C., Shi, K., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04343-z · Cited by 2
“In addition, the loss of NLRP3 and IL-18 impairs the production and activation of tumor suppressors such as STAT1 and interferon-gamma (IFN-γ), increasing the risk of colorectal cancer [97].”
Role of Inflammasomes in the Development of Gastrointestinal Diseases
Kanak, M. A., Shindo, Y., SaiKumar, P., & Naziruddin, B. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_10 · Cited by 2
Chronic Obstructive Pulmonary Disease COPD and lung cancer: is the inflammasome at the cross-talk?
Colarusso, C. (2022) · doi:10.36118/pharmadvances.2021.25 · Cited by 2
“Although Casp1-/-Casp11129mt/129mt mice showed enhanced tumorigenesis during colitis-associated cancer development (16-18), the absence of caspase-1/-11 signifi cantly reduced the establishment of lung adenocarcinoma (9, 12).”
BackgroundHe, J., Jia, J., Lei, J., Yu, J., Zhou, W., & Zhang, M. (2023) · Cancer Biomarkers · doi:10.3233/cbm-220362 · Cited by 2
“It can reduce tumor growth and angiogenesis in liver cancer, skin carcinoma, and colorectal cancer [41,42], but it has a double-way effect mechanism in breast cancer [43].”
Inflammatory caspase-1, -4, and -5 and their role in anticancer activity
Shakya, R., Navneesh, Pandey, S., Pasricha, S., Kurmi, B. D., & Patel, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15644-1.00003-1 · Cited by 2
Inflammasomes and Inflammation
Chen, K. W., Richards, A. A., Zamoshnikova, A., & Schroder, K. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch8 · Cited by 2
Nong, S., Guan, Y., Wang, Z. P., Wei, Z., Zhang, Y., Ni, J., He, C., Ma, L., Zhou, S., & Li, W. (2019) · Oncology and Translational Medicine · doi:10.1007/s10330-019-0342-2 · Cited by 2
BACTERIAL SPHINGOLIPIDS EXACERBATE COLITIS BY INHIBITING ILC3-DERIVED IL-22 PRODUCTION
Bao, B., Wang, Y., Boudreau, P., Song, X., Wu, M., Chen, X., Patik, I., Tang, Y., Ouahed, J., Ringel, A., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2023.11.200 · Cited by 2
Inflammasomes : des mécanismes d’activation de la caspase-1 à la progression tumorale
Guey, B. (2016) · theses.fr (ABES) · doi:10.70675/42ebd7a3zcde2z449czb32cz9db33732e38c · Cited by 2
Geisler, L. J., Detjen, K. M., Hellberg, T., Kohlhepp, M. S., Grötzinger, C., Knorr, J., Eichhorn, I., Mohr, R. U., Holtmann, T. M., Wiedenmann, B., et al. (2025) · Cells · doi:10.3390/cells14020111 · Cited by 1
“By regulating immune cell activation, cellular proliferation and cell death in various organs [41] the inflammasome has been shown to mediate antitumoral immunity [42] but also cancer-promoting function [43].”
Ma, S., Wang, X., Li, M. D., Wang, W., Ren, Y., Shen, Y., Ke, Y., Zhang, Z., Feng, Z., & Tang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1806088 · Cited by 1
Kim, Y. W., Lee, S. J., Lee, W. M., Kim, S.-J., & Ahn, D. (2026) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2602.02038 · Cited by 1
“The receptors involved in CoV infections include hACE2, hDPP4, DC-SIGN DC-SIGN, and L-SIGN, each playing distinct roles in viral pathogenesis and immune modulation [107-109]. hACE2 (human angiotensin-converting enzyme 2) is the primary receptor for SARS-CoV and SARS-CoV-2 [110].”
Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer
Guo, K., Feng, Y., Lu, J. J., Abudurexiti, N., Zhou, X., Wei, M., & Zheng, S. (2026) · Cancer Science · doi:10.1111/cas.70426 · Cited by 1
“Studies have shown that mice deficient in NLRP3 are highly susceptible to dextran sulfate sodium (DSS)- induced colitis due to markedly reduced IL-18 levels leading to impaired production of the tumor suppressor interferon gamma (IFN-γ) and defective activation of STAT1 [115].”
Crohn's Disease Enteritis: Pathophysiological Mechanisms and Therapeutic Approaches
Jia, L., & Wang, H. (2026) · Scandinavian Journal of Immunology · doi:10.1111/sji.70129 · Cited by 1
“These immunological differences may have significant therapeutic implications, potentially explaining variable patient responses to biologics that target specific cytokine pathways [82, 83].”
Rossi, M., SPANO, A., Fortun, A., Camilleri, N., Magatti, M., Papait, A., Silini, A. R., & Parolini, O. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1856903 · Cited by 1
“Macrophages represent the primary source of inflammasome-derived cytokines, with NLRP3 integrating signals from pattern recognition receptors, metabolic stress, and microbial dysbiosis (Song et al., 2021), (Zaki et al., 2010b).”
Aryl Hydrocarbon Receptor Suppresses Cecal Carcinogenesis
Ikuta, T., Kobayashi, Y., Fujii‐Kuriyama, Y., & Kawajiri, K. (2014) · Springer eBooks · doi:10.1007/978-4-431-54992-5_13 · Cited by 1
“Recent studies also showed that IL-18 production is critically involved in protection against colorectal tumorigenesis (Zaki et al. 2010).”
BackgroundNOD-Like Receptors in Colon Tumorigenesis
Zaki, H. (2013) · ImmunoGastroenterology · doi:10.7178/ig.35 · Cited by 1
Rébé, C., Perrichet, A., & Ghiringhelli, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00009-8 · Cited by 1
Ikushima, H., Yanai, H., & Taniguchi, T. (2015) · Springer eBooks · doi:10.1007/978-4-431-55327-4_7 · Cited by 1
Inflammasome Activation by Paramyxoviruses
Shil, N. K., Pokharel, S. M., & Bose, S. (2017) · Current Clinical Microbiology Reports · doi:10.1007/s40588-017-0070-x · Cited by 1
Inflammatory Biomarkers for Cancer
Corthay, A., & Haraldsen, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_10 · Cited by 1
Prayitno, A. (2019) · Dental Journal (Majalah Kedokteran Gigi) · doi:10.20473/j.djmkg.v52.i2.p105-109 · Cited by 1
The significance of serum IL-18 levels in Hodgkin lymphoma patients
Sincan, G., Sincan, S., Kızıltunç, Ç., & Eğilmez, E. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157044 · Cited by 1
Pattern Recognition Receptors and Aging
Shalaby, K. H. (2013) · Springer eBooks · doi:10.1007/978-3-642-39495-9_8 · Cited by 1
INFLAMMATION AND INTESTINAL HOMEOSTASIS-ASSOCIATED GENES IN COLORECTAL CANCER
Ungerbäck, J. (2012) · DiVA (Linkoping University) · Cited by 1
The inflammatory caspases coordinate mucosal restriction of Salmonella enterica serovar Typhimurium
Crowley, S. M. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0389696 · Cited by 1
Role of NLRP3 in colitis and colitis associated colorectal cancer
Perera, A. P. (2019) · UTAS Research Repository · doi:10.25959/100.00034330 · Cited by 1
The role of Dietary Interventions in Broiler Intestinal Health and Immunity
McCaffrey, C. (2017) · Arrow@dit (Dublin Institute of Technology) · Cited by 1
Glycosylation of FIP-nha and its biological properties
Liu, Y. (2024) · doi:10.18174/652205 · Cited by 1
STING ACTIVATING PARTICLES FOR CANCER IMMUNOTHERAPY
Cheng, N. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ncwm-eb07 · Cited by 1
Piste infectieuse à Escherichia coli toxinogènes dans le cancer colorectal
Raisch, J. (2014) · theses.fr (ABES) · doi:10.70675/d8946435z5f92z4b9az894az6d7593f00e77 · Cited by 1
Morales, C. (2013) · OpenCommons at University of Connecticut (University of Connecticut)
Immune Molecules Regulate Medulloblastoma and Neuronal Apoptosis
Knight, E. R. W. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/cqj0-1729
Étude du rôle de l’autophagie dans la cancérogenèse intestinale
Levy, J. (2014) · theses.fr (ABES) · doi:10.70675/2a7b0f33zed43z4b27z8afaz3b6a980e5541
“Recent reports demonstrate that the inflammasome protein NLRP3 is a negative regulator of tumorigenesis during carcinogen-induced colon cancer [44, 45].”
BackgroundImplication de l'interleukine-18 dans la cytotoxicité anti-tumorale des polynucléaires éosinophiles
Gatault, S. (2015) · theses.fr (ABES) · doi:10.70675/0e9d820bz6f4dz4f96z9742za1ecd1e4a17f
Regan, T. W. (2014) · Arrow@dit (Dublin Institute of Technology)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Dunn, J. H., & Fujita, M. (2015)
Caracterización de la microbiota intestinal mediante "NGS" en patología neoplásica de colón
Ros, J. G. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
The protective roles of NLRs during infection and tumor progression
Janowski, A. M. (2016) · doi:10.17077/etd.nm4711us
“Expression of NLRP3 was shown to be important for prevention of colitis-associated colorectal cancer (52, 53).”
BackgroundCharacterization of TLR7-independent effects of Imidazoquinolines
Groß, C. J. (2016)
Innate Immune Receptors in the Regulation of Tumor Immunity
Hangai, S., Kimura, Y., Taniguchi, T., & Yanai, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_25
Regulation of Gene Expression in Cancer: The Relationship of STAT1, MMP-1 and MMP-3
Cutler, S. J. (2012) · Griffith Research Online · doi:10.25904/1912/1038
Inflammasome regulation and activation in the intestinal epithelium
Lei, A. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-mzngoy5ob
The role of tyrosine phosphorylation in inflammasome complex formation and function.
Mambwe, B. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Roles of Cytosolic Nucleic Acid Sensors in Cancer and Infection
Zu, Q. (2018) · doi:10.21007/etd.cghs.2018.0462
“Caspase-1-mediated release of IL-18 following inflammasome activation has been shown to play a protective role in preventing AOM-DSS-induced colitis and colitisassociated colorectal tumorigenesis [27-29, 111].”
BackgroundInfluential
Metadata
- Authors
- Zaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., & Kanneganti, T.-D.
- Affiliations
- Department of Immunology , Memphis, TN 38105
- St. Jude Children's Research Hospital (US)
- Department of Physiopathology of Inflammatory Bowel Diseases, INSERM Unité 995 , Lille ,
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Kanneganti, Thirumala-Devi
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 185
- Issue
- 8
- Pages
- 4912-4920
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3104023
- OpenAlex
- W1954263225
- Cited by
- 411
- References
- 62
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 39 · 2023: 26 · 2022: 42 · 2021: 43 · 2020: 20 · 2019: 30 · 2018: 26 · 2017: 24 · 2016: 22 · 2015: 26 · 2014: 18 · 2013: 25 · 2012: 20
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Yale University
- St. Jude Children's Research Hospital
- American Lebanese Syrian Associated Charities (AR056296, CA 21765)
- Vlaamse regering
- National Institutes of Health (CA21765))
- Takeda Oncology
- National Cancer Institute (2 P30 CA21765, P30CA021765)
- National Institute of Allergy and Infectious Diseases (AI088177, R21AI088177)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056296, AR-056296)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-18, NLRP3 inflammasome, colorectal cancer, colorectal carcinogenesis, caspase-1, interferon-gamma, STAT1, chronic inflammation, azoxymethane/dextran sulfate sodium, tumor suppression
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cell Transformation, Neoplastic, Enzyme-Linked Immunosorbent Assay, Inflammation, Mice, Inbred C57BL, Blotting, Western, Colorectal Neoplasms, Cytokines, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-18, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.